CA
Trees Corporation
CANN · OTC
$0.02 +6.67% (+$0.00)
1M +9.32%
Market Cap $1.79M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.02
13.6% upside
Current Price
$0.018
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CANN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
40 /100
Fair EV/EBITDA 22.22x
P/S 0.13x
P/E N/A
Growth
0 /100
Declining Rev. growth 4.62%
EPS growth N/A
Book val. growth N/A
Profitability
17 /100
Weak Gross margin 42.59%
FCF margin 5.16%
Net margin 30.41%
Quality
12 /100
Poor ROIC 6.86%
Asset turnover 0.66x
ROA 20.00%
Debt
0 /100
High Current ratio 0.16x
Net debt/EBITDA 20.11x
Int. coverage -0.01x
Stability
47 /100
Moderate Beta -0.51x
Profitable years 0
Rev. volatility 31.89%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CANN
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Adam L. Hershey
Employees
91
Headquarters
Lakewood